Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
PACIRA PHARMACEUTICALS INC

PACIRA PHARMACEUTICALS INC Recalls

All product recalls associated with PACIRA PHARMACEUTICALS INC.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jun 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–4 of 4 recalls

Zilretta (Pacira) – Dissolution Specifications (2024)

Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

Class IIModerate

FDAJun 12, 2024Nationwide• PACIRA PHARMACEUTICALS INC

Zilretta Injection (Pacira) – Stability Specification Failure (2024)

Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.

Class IIModerate

FDAMay 7, 2024Nationwide• PACIRA PHARMACEUTICALS INC

EXPAREL Bupivacaine Suspension (Pacira) – Potency Issue (2019)

Sub Potent Drug: Out of Specification (OOS)

Class II

Moderate

FDANov 21, 2019Nationwide• Pacira Pharmaceuticals, Inc.

Exparel (Pacira Pharmaceuticals) – Subpotent Medication (2012)

Subpotent; bupivacaine

Class IIModerate

FDADec 17, 2012Nationwide• Pacira Pharmaceuticals, Inc.